Xetomed-MR Tablet is a combination medication containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, formulated for the management of musculoskeletal pain and inflammation. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that provides effective analgesic and anti-inflammatory effects by reducing the synthesis of prostaglandins involved in pain and inflammation pathways. Thiocolchicoside is a muscle relaxant with antispasmodic properties that acts on glycine and GABA receptors to alleviate muscle stiffness and spasms. The synergistic action of these two agents makes Xetomed-MR Tablet particularly useful in conditions such as acute musculoskeletal disorders, low back pain, osteoarthritis, and other inflammatory rheumatic diseases where both pain relief and muscle relaxation are desired. This combination offers improved patient compliance by addressing multiple symptoms with a single dosage form. Xetomed-MR should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, severe hepatic or renal impairment, and cardiovascular risks. Caution is advised in patients with a history of cardiovascular disease or gastrointestinal bleeding. The recommended dosage and duration of therapy should be tailored to individual patient needs to maximize therapeutic benefits while minimizing potential adverse effects.